test

Ron Rosenstraus

@Eversept Partners, Lp

Latest period2024 - Q3ReportedManaged Assets$1.46BTotal holdings67
Assets growth rate-0.03%Assets growth rate (2-Q avg)-1.3%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Eversept Partners, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 67 positions.

Assets under management

The assets under management (AUM) of Eversept Partners, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.46B in assets, with a quarterly growth rate of -0.03% and a 2-quarter average growth rate of -1.3%. The portfolio is managed by Ron Rosenstraus, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CLDXCelldex Therapeutics Inc New
Recent Activity
Decreased -10.76%
1.32%
$19.201M
564,902 shares@ $34.0 avg price
MNKDMannkind Corp
Recent Activity
Decreased -11.71%
0.86%
$12.533M
1.993M shares@ $6.29 avg price
TVTXTravere Therapeutics Inc
Recent Activity
Decreased -20.27%
0.84%
$12.17M
869,913 shares@ $14.0 avg price
HUMHumana Inc
Recent Activity
Decreased -10.94%
0.74%
$10.725M
33,860 shares@ $316.74 avg price
DHRDanaher Corporation
Recent Activity
Decreased -5.93%
0.74%
$10.684M
38,429 shares@ $278.03 avg price
EOLSEvolus Inc
Recent Activity
Decreased -21.13%
0.51%
$7.34M
453,061 shares@ $16.2 avg price
ARQTArcutis Biotherapeutics Inc
Recent Activity
Decreased -17.25%
0.45%
$6.447M
693,263 shares@ $9.31 avg price
BKDBrookdale Sr Living Inc
Recent Activity
Decreased -44.32%
0.41%
$5.848M
861,268 shares@ $6.8 avg price
NAMSNewamsterdam Pharma Company
Recent Activity
Decreased -6.83%
0.35%
$5.102M
307,357 shares@ $16.6 avg price
GOSSGossamer Bio Inc
Recent Activity
Decreased -9.22%
0.34%
$4.911M
4.978M shares@ $0.99 avg price